Pfizer Sues Ranbaxy, Teva Over Accupril Patent

Law360, New York (February 21, 2005, 12:00 AM EST) -- Pfizer Inc. has sued India’s Ranbaxy and Israel’s Teva Pharmaceuticals in New Jersey federal court, alleging that the two companies are infringing a process patent for the hypertension drug Accupril.

The lawsuit, filed in late January in the U.S. District Court for the District of New Jersey, alleges that Ranbaxy infringes a process patent held by Parke-Davis, which was later acquired by Pfizer.

Ranbaxy's generic version reaches the U.S. market under Teva’s label through a supply agreement between the two companies.

Teva was granted six-month marketing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.